6550.TW

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
6550.TWPolaris Group	$9.97	+0.71%	$8.9B	—
4123.TWOCenter Laboratories, Inc.	$30.45	+0.33%	$23.0B	—
4147.TWOTaiMed Biologics Inc.	$60.90	+2.18%	$16.5B	—
4728.TWOSunmax Biotechnology Co., Ltd.	$391.50	-0.89%	$21.3B	—
4743.TWOOneness Biotech Co., Ltd.	$43.75	+0.57%	$21.0B	—
6491.TWPegavision Corp.	$385.00	-1.28%	$29.6B	—
6541.TWTanvex BioPharma, Inc.	$30.70	+1.32%	$8.1B	—

Source: Financial Modeling Prep · peers by sector/industry

Polaris Group

Polaris Group, together with its subsidiaries, offers biotechnology, drug testing, and contract development and manufacturing services. The company engages in the research, development, manufacture and sale of new drugs. It develops ADI-PEG 20 for the treatment of various cancer indications, as well as provides healthcare consulting, staffing, and MDS solutions. The company was incorporated in 2006 and is based in Grand Cayman, Grand Cayman.

www.polaris-group.com

Employees: 83,293
IPO / List date: Feb 15, 2016
HQ: KY

Held by traders on TradeandTell

No one on the platform currently holds 6550.TW.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in 6550.TW as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded 6550.TW yet.